Back to all papers

Predicting ISUP upgrading from biopsy to radical prostatectomy using an interpretable machine learning model with mpMRI-diagnosed prostatitis: a retrospective study.

November 17, 2026pubmed logopapers

Authors

Wang SY,Jin LC,Tian Z,Jia ZM,Li GZ,Chen X,Wei XD,Huang C,Huang YH

Affiliations (2)

  • Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
  • Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.

Abstract

The International Society of Urological Pathology (ISUP) grade upgrading from biopsy to radical prostatectomy (RP) occurs in approximately 30%-40% of prostate cancer patients and may compromise treatment planning. Although multiparametric MRI (mpMRI) improves lesion characterization, prostatitis-like signal changes can mimic clinically significant cancer and confound radiological interpretation; however, no predictive model has incorporated mpMRI-diagnosed prostatitis as a variable for ISUP upgrading. This single-center retrospective study enrolled 503 consecutive men who underwent "12+1"-core transperineal ultrasound-guided systematic biopsy supplemented by cognitive mpMRI-targeted cores followed by laparoscopic RP (from May 2021 to October 2024). Least absolute shrinkage and selection operator (LASSO) logistic regression with 10-fold cross-validation was used for feature selection, and six machine learning classifiers were trained and evaluated on an independent test set (7:3 split). ISUP upgrading occurred in 195 patients (38.8%), and mpMRI-diagnosed prostatitis was significantly more prevalent in upgraded cases (27.2% vs 11.4%, P < 0.001). The random forest model achieved the highest weighted composite score (area under the receiver operating characteristic curve [ROC-AUC]: 0.823; average precision: 0.799) and was selected as the final model. SHapley Additive exPlanations (SHAP) analysis ranked feature importance as: basal tumor location (mean |SHAP|: 0.145), Prostate Imaging Reporting and Data System (PI-RADS) ≥4 (mean |SHAP|: 0.121), percentage of positive cores (mean |SHAP|: 0.100), maximum tumor diameter (mean |SHAP|: 0.062), and mpMRI-diagnosed prostatitis (mean |SHAP|: 0.040). As one of the first models to incorporate mpMRI-diagnosed prostatitis, this SHAP-interpretable framework showed that such prostatitis adds predictive value beyond PI-RADS scoring. This may help identify patients at heightened risk of undergrading on biopsy.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.